[First clinical trials of treatment of primary liver cancer with immunostimulating agents administered by systemic or intratumoral route].
作者信息
Tung T T, Bang N H, Van Ton N V, Bach T, Tam N D, Salomon J C
出版信息
Chirurgie. 1975;101(8):542-5.
PMID:170046
Abstract
摘要
相似文献
1
2
Assessment of the palliative treatment in primary liver cancer.原发性肝癌姑息治疗的评估
J Med Assoc Thai. 1979 Sep;62(9):487-93.
3
[Immunotherapy of lung cancer].[肺癌的免疫疗法]
Pol Tyg Lek. 1982 Jun 14;37(17):497-9.
4
Primary liver cancer in Thailand.
Trop Gastroenterol. 1984 Apr-Jun;5(2):75-82.
5
Treatment of neoplasms of the liver.
Am J Gastroenterol. 1969 Oct;52(4):326-33.
6
[Primary liver cancer. Personal experience in diagnosis and therapy].[原发性肝癌。诊断与治疗的个人经验]
Cas Lek Cesk. 1988 Mar 4;127(10):298-301.
7
Effect of immunostimulating agents on viral infections.
Acta Microbiol Acad Sci Hung. 1981;28(3):325-37.
8
Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver.肝动脉暂时阻断联合灌注及全身化疗治疗无法切除的肝癌
Int Surg. 1980 Jul-Aug;65(4):315-23.
9
Primary carcinoma of the liver.
Surgery. 1976 Sep;80(3):322-7.
10
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.卡介苗免疫药理学在免疫治疗中积累的经验催生了第二代全身免疫佐剂。
Comp Immunol Microbiol Infect Dis. 1980;3(4):407-32. doi: 10.1016/0147-9571(80)90017-x.
Zotero 插件